New Horizon Health, a commercial-stage biotech company principally engaged in developing and commercialising innovative cancer screening products, has raised around HK$780m from a share placement. It placed 27.5 million shares…
New Horizon Health, a commercial-stage biotech company principally engaged in developing and commercialising innovative cancer screening products, has raised around HK$780m from a share placement. It placed 27.5 million shares…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference